Clinical Trial Update: A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating the effect of MAALOX on raltegravir in HIV-infected participants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• MAALOX (unknown)
• Raltegravir (raltegravir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2014-11-03